CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women

Bibliographic Details
Main Authors: Cheryl Baxter, Nonhlanhla Yende Zuma, Natasha Samsunder, Salim Abdool Karim, Catherine Hankins, Quarraisha Abdool Karim, Bruno Pozzetto, Leila Mansoor, Tanuja Narayansamy Gengiah, Ishana Harkoo, Precious Radebe, B Maharaj, Marc M Baum, John A Moss
Format: Article
Language:English
Published: BMJ Publishing Group 2022-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/1/e052880.full